Bitmine Makes Biggest Ethereum Purchase Of The Year

1 month ago 18

CryptoProwl

Mon, April 20, 2026 astatine 8:36 AM CDT 1 min read

Bitmine Makes Biggest Ethereum Purchase Of The Year

Bitmine Makes Biggest Ethereum Purchase Of The Year

BitMine Immersion Technologies (NYSE: $BMNR) bought $230 cardinal U.S. of Ethereum (CRYPTO: $ETH) implicit the past week, its largest acquisition of the year. 

BitMine, which is the largest firm acquirer of ETH, accelerated its crypto purchases arsenic Chairman Tom Lee called a bottommost successful the cryptocurrency’s price.

The institution bought 101,627 Ethereum past week, its largest play haul since Dec. 15 of past year. The acquisition outgo $230 cardinal U.S. astatine existent prices.

More From Cryptoprowl:

  • Ripple, The Company Behind XRP, Is Valued At $50 Billion

  • Eightco Secures $125 Million Investment From Bitmine And ARK Invest, Shares Surge

  • Blockchain Projects Decline 75% As Developers Shift To A.I.

  • Stanley Druckenmiller Says Stablecoins Could Reshape Global Finance

  • New York Stock Exchange Invests $600 Million In Polymarket

BitMine present owns 4.97 cardinal ETH worthy $11.43 cardinal U.S. based connected the contiguous terms of $2,300 U.S. per integer token. 

Analysts enactment that BitMine remains 1 of the past large-scale buyers of ETH, providing a dependable root of request for the 2nd largest cryptocurrency by marketplace capitalization.

BitMine’s full crypto and currency holdings present basal astatine $12.90 cardinal U.S. In summation to ETH, the steadfast owns 199 Bitcoin (CRYPTO: $BTC) and $1.12 cardinal U.S. of cash.

Lee said successful caller media interviews that helium sees signs of a bottommost successful Ethereum, pointing to broader marketplace dynamics and an presumption of bid successful the Middle East.

Lee notes that Ethereum has risen sharply from its aboriginal February lows and has outperformed stocks since the commencement of the Iran struggle connected Feb. 28. 

Ethereum is presently trading astatine $2,300 U.S. BMNR banal has declined 30% this twelvemonth to commercialized astatine $22.07 U.S. per share. 

Read Entire Article